May 8th 2025
Adial Pharmaceuticals advances its treatment for alcohol use disorder, AD04, with FDA meetings and promising genetic insights for targeted therapy.
Is the Case Settled? Cannabis and Criminal Responsibility
January 13th 2025Understanding the complex relationship between substance use and mental health is critical to providing thorough and well-informed evaluations. Let's take a look at the relationship between cannabis and criminal responsibility.
Read More
Beyond Abstinence: Other Clinically Meaningful Endpoints for Patients With Substance Use Disorders
December 9th 2024While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!
Read More